Surgical Volume, Safety, Drug Administration, and Clinical Trials During COVID-19: Single-center Experience in Shanghai, China

Eur Urol. 2020 Jul;78(1):120-122. doi: 10.1016/j.eururo.2020.04.026. Epub 2020 Apr 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Betacoronavirus*
  • COVID-19
  • China / epidemiology
  • Clinical Trials as Topic / methods*
  • Coronavirus Infections / epidemiology*
  • Female
  • Humans
  • Incidence
  • Male
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2
  • Treatment Outcome
  • Urogenital Neoplasms / complications
  • Urogenital Neoplasms / epidemiology
  • Urogenital Neoplasms / therapy*
  • Urogenital Surgical Procedures / statistics & numerical data*

Substances

  • Antineoplastic Agents